Concert Pharmaceuticals, Inc. (CNCE) was a big mover last session, as the company saw its shares rise roughly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the trend for the company since Feb 27, as the stock is now trading above the volatile price range of $13.86 to $14.73.
Over the last 30 days, this company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Concert Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the med-drugs industry may also consider Lannett Company, Inc. (LCI) which sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment